Corner Office Conversation with Eli Lilly's Global CEO David Ricks

Eli Lilly has launched its obesity and diabetes drug Mounjaro (Tirzepatide) in India. Weight loss drugs, a pharmaceutical segment that has taken the world by storm, has catapulted Eli Lilly to being the world’s most valuable company with a market cap of over $800 billion. In this episode, ET’s Vikas Dandekar and Teena Thacker speak with global CEO David Ricks and Winselow Tucker, President & GM India, about new breakthroughs in drug development, competition, and the role of emerging markets. They also discuss strategic partnerships, political challenges like tariffs, and Eli Lilly’s commitment to funding innovation and advancing global healthcare.

Tune in.

You can follow Vikas Dandekar on his Linkedin, Twitter profiles and read his Newspaper Articles.

You can follow Teena Thacker on her Linkedin, Twitter profiles and read his Newspaper Articles. 

If you like this episode, check out more Corner Office Conversations from the podcast: Adar Poonawalla, Sandip Patel, The Mega Listing Of Vishal Retail, Antonoaldo Neves, Rajesh Jejurikar, Srikanth Velamakanni, and more!

Catch the latest episode of ‘The Morning Brief’ on ET Play, The Economic Times Online, Spotify, Apple Podcasts, JioSaavn, Amazon Music and Youtube.

See omnystudio.com/listener for privacy information.